Non-Separable Preferences in the Statistical Analysis of Roll Call Votes
Political Analysis · 2023-07 · 31 (3) · 352-365
DOI: 10.1017/pan.2022.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Political Analysis, online erschienen am 24.05.2022. Verfasst von Garret Binding und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Conventional multidimensional statistical models of roll call votes assume that legislators’ preferences are additively separable over dimensions. In this article, we introduce an item response model of roll call votes that allows for non-separability over latent dimensions. Conceptually, non-separability matters if outcomes over dimensions are related rather than independent in legislators’ decisions. Monte Carlo simulations highlight that separable item response models of roll call votes capture non-separability via correlated ideal points and higher salience of a primary dimension. We apply our model to the U.S. Senate and the European Parliament. In both settings, we find that legislators’ preferences over two basic dimensions are non-separable. These results have general implications for our understanding of legislative decision-making, as well as for empirical descriptions of preferences in legislatures.
Zitieren
APA
Binding, G., & Stoetzer, L. F. (2023). Non-Separable Preferences in the Statistical Analysis of Roll Call Votes. Political Analysis, 31(3), 352-365. https://doi.org/10.1017/pan.2022.11
Vancouver
Binding G, Stoetzer LF. Non-Separable Preferences in the Statistical Analysis of Roll Call Votes. Political Analysis. 2023;31(3):352-365. doi:10.1017/pan.2022.11
BibTeX
@article{Binding2023,
author = {Binding, Garret and Stoetzer, Lukas F.},
title = {Non-Separable Preferences in the Statistical Analysis of Roll Call Votes},
journal = {Political Analysis},
year = {2023},
volume = {31},
number = {3},
pages = {352--365},
doi = {10.1017/pan.2022.11}
}
EUVIMED